INCYTE CORP
Develops proprietary therapeutics for serious unmet needs in oncology and inflammation.
INCY | NDAQ
Overview
Corporate Details
- ISIN(s):
- US45337C1027
- LEI:
- Country:
- United States of America
- Address:
- 1801 AUGUSTINE CUT-OFF, 19803 WILMINGTON
- Website:
- https://www.incyte.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Incyte Corporation is a global biopharmaceutical company focused on the discovery, development, and commercialization of proprietary therapeutics. The company leverages scientific innovation to address serious unmet medical needs, primarily in the fields of oncology and inflammation. Incyte maintains a diversified portfolio of marketed products and a robust pipeline of clinical candidates targeting various diseases, including hematological malignancies and myeloproliferative neoplasms (MPNs). The company is committed to creating innovative solutions for patients through its research and development efforts.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all INCYTE CORP filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for INCYTE CORP
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for INCYTE CORP via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
